tegafur has been researched along with Neoplasms, Bronchial in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Dose escalation was required in order to control carcinoid symptoms, and the final dosage was 5,950 micrograms/day." | 1.29 | Long-term survival in a patient with malignant carcinoid treated with high-dose octreotide. ( Deguchi, H; Deguchi, K; Iwasaki, E; Kobayashi, T; Murashima, S; Shirakawa, S; Tsuda, M; Tsukada, T, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deguchi, H | 1 |
| Deguchi, K | 1 |
| Tsukada, T | 1 |
| Murashima, S | 1 |
| Iwasaki, E | 1 |
| Tsuda, M | 1 |
| Kobayashi, T | 1 |
| Shirakawa, S | 1 |
1 other study available for tegafur and Neoplasms, Bronchial
| Article | Year |
|---|---|
Long-term survival in a patient with malignant carcinoid treated with high-dose octreotide.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Carcinoid Tumor; Combined Modal | 1994 |